# The Fires of Isengard Have Spread: Serratia sarumanii Is the Dominant Species in Clinical Isolates of the “Serratia marcescens Complex”

**Authors:** Levin Joe Klages, Julia Hassa, Tobias Busche, Olaf Kaup, Christiane Scherer, Claudia Christine Freytag, Thorsten Kaiser, Jörn Kalinowski, Christian Rückert-Reed

PMC · DOI: 10.3390/pathogens15020140 · Pathogens · 2026-01-28

## TL;DR

This study shows that Serratia sarumanii, not Serratia marcescens, is the most common species in clinical isolates of the Serratia marcescens complex.

## Contribution

The paper identifies S. sarumanii as the dominant clinical species in the S. marcescens complex using genome sequencing and global genomic data.

## Key findings

- Out of 21 isolates from hospitals in OWL, 10 were identified as S. sarumanii.
- Approximately one-third of Serratia genomes in GenBank were reclassified as S. sarumanii.
- S. sarumanii is the most dominant Serratia species in clinical settings globally.

## Abstract

Recently, a new species, Serratia sarumanii, was described, belonging to a group of strains previously identified as Serratia marcescens in routine clinical analyses. It was shown that the identification of S. marcescens isolates by biochemical testing, mass spectrometry, or 16S rRNA gene sequencing was insufficient to resolve the ‘S. marcescens complex’, while sampling point analysis revealed that many genomes assigned to the S. sarumanii cluster were associated with a clinical context. Thus, here the clinical relevance and local as well as global distribution of S. sarumanii is analyzed. In total, 21 strains from three hospitals in Eastern Westphalia-Lippe (OWL), previously identified as S. marcescens and potential causative agents from severe bacterial infections, were analyzed by genome sequencing and species identification. It could be shown that only one isolate was confirmed as S. marcescens, whereas 10 of the 21 isolates were identified as S. sarumanii, indicating that S. sarumanii is the dominant representative of the “Serratia marcescens” complex in hospitals in OWL. To analyze the global species distribution, all Serratia genomes available in GenBank were reclassified. About one-third of these genomes were identified as S. sarumanii, indicating S. sarumanii as the most dominant Serratia species in clinical settings around the world.

## Linked entities

- **Species:** Serratia sarumanii (taxon 3020826), Serratia marcescens (taxon 615)

## Full-text entities

- **Genes:** DYM (dymeclin) [NCBI Gene 54808] {aka DMC, SMC}
- **Diseases:** injury to (MESH:D014947), meningitis (MESH:D008580), keratitis (MESH:D007634), infection (MESH:D007239), bacterial (MESH:D001424), bloodstream infections (MESH:D018805)
- **Chemicals:** formic acid (MESH:C030544), acetonitrile (MESH:C032159), carbapenem (MESH:D015780), prodigiosin (MESH:D011353), CP142097 (-), K (MESH:D011188), alpha-cyano-4-hydroxycinnamic acid (MESH:C007175), TFA (MESH:D014269), BA (MESH:D001464)
- **Species:** Serratia bockelmannii (species) [taxon 2703793], Serratia nevei (species) [taxon 2703794], Enterobacterales (order) [taxon 91347], Yersinia pestis (species) [taxon 632], Serratia nematodiphila (species) [taxon 458197], Serratia ureilytica (species) [taxon 300181], Homo sapiens (human, species) [taxon 9606], Serratia marcescens (species) [taxon 615]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942993/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942993/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942993/full.md

---
Source: https://tomesphere.com/paper/PMC12942993